FDA inspection
Changzhou Qianhong Biopharma Co., Ltd.: FDA inspection ending Oct 23, 2019
FDA inspection 1112213 · No Action Indicated (NAI) · Changzhou
Key facts
| Inspection ID | 1112213 |
|---|---|
| Firm | Changzhou Qianhong Biopharma Co., Ltd. |
| FEI number | 3005275502 |
| Address | 192 Huanghe West Road, Xinbei District |
| City | Changzhou |
| Country | China |
| Fiscal year | 2020 |
| Inspection end date | Oct 23, 2019 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data